Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2016 · 10-Q
Revenue$68.58M$68.58M+4.0% vs Q3 2015 Net Income$6.07M$6.07M+10.2% vs Q3 2015 EPS Diluted$0.51$0.51+10.9% vs Q3 2015 Gross Profit$52,163,000+6.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,941,000−26.6% Free Cash Flowderived$5,655,000−38.7% Margins · derivedGross margin76.1%+1.5 pt vs Q3 2015
Operating margin13.1%+1.0 pt vs Q3 2015
Net margin8.8%+0.5 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end